Modality.AI - About the company
Modality.AI is a seed company based in San Francisco (United States), founded in 2018 by David Suendermann-Oeft, David Pautler and David Fox. It operates as a Provider of AI-based clinical trial therapies for neurological and mental conditions. Modality.AI has raised an undisclosed amount in funding from Alchemist Accelerator. The company has 1428 active competitors, including 340 funded and 184 that have exited. Its top competitors include companies like Verily, IQVIA and Innovaccer.
Company Details
Modality is a provider of AI-based clinical trial therapy for neurological and mental conditions. It provides audio-visual biomarkers to analyzes speech responses and facial behaviors. It is used for ALS, autism, depression, and anxiety, Alzheimer's disease, and others.
- Website
- modality.ai
- Social
- Email ID
- *****@modality.ai
Key Metrics
Founded Year
2018
Location
San Francisco, United States
Stage
Seed
Latest Funding Round
Investors
Ranked
354th among 1428 active competitors
Employee Count
33 as on Aug 31, 2026
Similar Companies
Sign up to download Modality.AI's company profile
Modality.AI's funding and investors
Modality.AI has raised funding over 3 rounds. Its first funding round was on Sep 2019. Its latest funding round was a Grant (prize money) round on Jun 03, 2025 for $*****. 1 investor participated in its latest round. Modality.AI has 8 institutional investors.
Here is the list of recent funding rounds of Modality.AI:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jun 03, 2025 | 2966932 | Grant (prize money) | 3600740 | 6105758 | 9283512 | 2892764 |
Jun 01, 2022 | 8580829 | Grant (prize money) | 3741767 | 1917500 | 7570491 | |
Sep 2019 | 9091727 | Seed | 4464880 | 9692278 | 1553194 |
Access funding benchmarks and valuations. Sign up today!View details of Modality.AI's funding rounds and investors
Modality.AI's founders and board of directors
Founder? Claim ProfileHere are the details of Modality.AI's key team members:
- David Suendermann-Oeft: Founder and Chief Executive Officer of Modality.AI.
- David Pautler: Co-Founder & CTO of Modality.AI. Contact Info: 1 email address
- David Fox: Chief Business Officer and Co-founder of Modality.AI and founder of 1 other company.
View details of Modality.AI's Founder profiles and Board Members
Modality.AI's employee count trend
Modality.AI has 33 employees as of Aug 26. Here is Modality.AI's employee count trend over the years:
Uncover Modality.AI's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Modality.AI's Competitors and alternates
Top competitors of Modality.AI include Verily, IQVIA and Innovaccer. Here is the list of Top 10 competitors of Modality.AI, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Verily 2015, Dallas (United States), Series D | A data platform and technology company purpose-built to power AI-enabled precision health | $2.8B | 82/100 | |
2nd |  IQVIA 1982, Durham (United States), Public | Provider of clinical research and commercialization solutions for healthcare | $1.74M | 79/100 | |
3rd |  Innovaccer 2014, San Francisco (United States), Series F | Developer of healthcare data platforms and artificial intelligence agent software | $675M | 78/100 | |
4th |  Tempus 2015, Chicago (United States), Public | Developer of genomic testing and artificial intelligence tools for medicine | $1.05B | 77/100 | |
5th | Manifold AI 2016, Oakland (United States), Series B | Provider of an AI platform for life sciences research and development | $40M | 72/100 | |
6th | Caris Life Sciences 1996, Irving (United States), Public | Developer of panomic disease profiling technologies for cancer precision medicine | $1.23B | 71/100 | |
7th |  Evidation 2012, Menlo Park (United States), Series E | Real-world health data insights for better healthcare decisions and research | $259M | 70/100 | |
8th | Hyro 2014, New York City (United States), Series C | Provider of an AI-based conversational platform | $115M | 70/100 | |
9th |  Inspiren 2016, Brooklyn (United States), Series C | AI based patient monitoring system for healthcare professionals | $225M | 70/100 | |
10th |  Artera 2021, Menlo Park (United States), Series A | AI-derived prognostic biomarker test for cancer detection | $135M | 68/100 | |
354th |  Modality.AI 2018, San Francisco (United States), Seed | Provider of AI-based clinical trial therapies for neurological and mental conditions | - | 36/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Modality.AI's competitors? Click here to see the top ones
Modality.AI's Investments and acquisitions
Modality.AI has made no investments or acquisitions yet.
Reports related to Modality.AI
Here is the latest report on Modality.AI's sector:
Are you a Founder ?
FAQs about Modality.AI
Explore our recently published companies
- Una Home Care - Beverly Hills based, 2026 founded, Unfunded company
- Boooply - 2026 founded, Unfunded company
- Uaity - 2026 founded, Unfunded company
